Rigel Pharmaceutical Inc. buy StockNews.com
Start price
23.09.23
/
50%
€1.00
Target price
23.09.24
-
Performance (%)
-22.75%
End price
24.09.24
-
Summary
This prediction is currently being closed. The price of Rigel Pharmaceutical Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -22.75%. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Rigel Pharmaceutical Inc. | - | - | - |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by StockNews_com for this prediction
In the thread Rigel Pharmaceutical Inc. diskutieren
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for RIGL provided by MarketBeat
In the thread Trading Rigel Pharmaceutical Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for Rigel Pharmaceutical Inc.
Rigel Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€1.37
12.03.24
12.03.24
-
12.03.25
12.03.25
-43.48%
13.03.25
13.03.25
Rigel Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€0.67
27.10.23
27.10.23
-
27.10.24
27.10.24
8.91%
28.10.24
28.10.24